The Business Journals

With cash running low, East Bay biotech Sangamo bets on FDA submission strategy

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Submitting its approval ...
Seeking Alpha

Sangamo rises as FDA accepts rolling submission request for gene therapy

Sangamo Therapeutics (SGMO) added ~9% in the premarket on Friday after the gene therapy developer said that the U.S. FDA accepted its request for a rolling submission and review of its marketing ...
The Verge

Screw it, I’m installing Linux

I don’t like where Windows is going. Gaming on Linux has never been more approachable. Time to give it a shot. If you buy something from a Verge link, Vox Media may earn a commission. See our ethics ...
Windows Central

The 7 apps I always install first on a Windows 11 PC — and they're all FREE

In a job like this, you spend more time than most setting up Windows 11 devices, and these are the first apps I have to install. When you purchase through links on our site, we may earn an affiliate ...
Greenwich Time

Sangamo: Q3 Earnings Snapshot

RICHMOND, Calif. (AP) — RICHMOND, Calif. (AP) — Sangamo Therapeutics Inc. (SGMO) on Thursday reported a loss of $34.9 million in its third quarter. The Richmond, California-based company said it had a ...